The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2016 | ESMO 2016: Press brief Q&A on topics discussed at this year’s meeting
In this press brief Q&A from ESMO 2016, Andrés Cervantes, MD, PhD of University of Valencia, Valencia, Spain, Solange Peters, MD, PhD of Lausanne University Hospital Lausanne, Switzerland and Ulrik Lassen, MD, PhD of Copenhagen University Hospital, Copenhagen, Denmark answer questions from the audience on this year’s meeting.
Recorded at the 2016 annual meeting of the European Society of Medical Oncology (ESMO), held in Copenhagen, Denmark.
